Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Leukemia

Free Subscription Articles published in Oncogene Retrieve available abstracts of 32 articles: HTML format Text format

Single Articles

January 2019
1. KARVONEN H, Perttila R, Niininen W, Hautanen V, et al
   Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
   Oncogene. 2019 Jan 10. pii: 10.1038/s41388-018-0670.
   PubMed     Text format     Abstract available
   
   
   December 2018
2. GIANNI M, Terao M, Kurosaki M, Paroni G, et al
   S100A3 a partner protein regulating the stability/activity of RARalpha and PML-RARalpha in cellular models of breast/lung cancer and acute myeloid leukemia.
   Oncogene. 2018 Dec 7. pii: 10.1038/s41388-018-0599.
   PubMed     Text format     Abstract available
   
   
   
3. TRAXEL S, Schadt L, Eyer T, Mordasini V, et al
   Bone marrow T helper cells with a Th1 phenotype induce activation and proliferation of leukemic cells in precursor B acute lymphoblastic leukemia patients.
   Oncogene. 2018 Dec 7. pii: 10.1038/s41388-018-0594.
   PubMed     Text format     Abstract available
   
   
   November 2018
4. URTISHAK KA, Wang LS, Culjkovic-Kraljacic B, Davenport JW, et al
   Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
   Oncogene. 2018 Nov 26. pii: 10.1038/s41388-018-0567.
   PubMed     Text format     Abstract available
   
   
   October 2018
5. MCLEAN K, Tan L, Bolland DE, Coffman LG, et al
   Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
   Oncogene. 2018 Oct 10. pii: 10.1038/s41388-018-0523.
   PubMed     Text format     Abstract available
   
   
   
6. CHONG PSY, Zhou J, Chooi JY, Chan ZL, et al
   Non-canonical activation of beta-catenin by PRL-3 phosphatase in acute myeloid leukemia.
   Oncogene. 2018 Oct 10. pii: 10.1038/s41388-018-0526.
   PubMed     Text format     Abstract available
   
   
   September 2018
7. CHIANG YJ, Liao WT, Ho KC, Wang SH, et al
   CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia.
   Oncogene. 2018 Sep 28. pii: 10.1038/s41388-018-0507.
   PubMed     Text format     Abstract available
   
   
   August 2018
8. SWAROOP A, Oyer JA, Will CM, Huang X, et al
   An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.
   Oncogene. 2018 Aug 31. pii: 10.1038/s41388-018-0474.
   PubMed     Text format     Abstract available
   
   
   
9. GOROSHCHUK O, Kolosenko I, Vidarsdottir L, Azimi A, et al
   Polo-like kinases and acute leukemia.
   Oncogene. 2018 Aug 13. pii: 10.1038/s41388-018-0443.
   PubMed     Text format     Abstract available
   
   
   July 2018
10. FERRANDINO F, Bernardini G, Tsaouli G, Grazioli P, et al
    Intrathymic Notch3 and CXCR4 combinatorial interplay facilitates T-cell leukemia propagation.
    Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0401.
    PubMed     Text format     Abstract available
    
    
    June 2018
11. ZHANG Y, Zhou X, Li Y, Xu Y, et al
    Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia.
    Oncogene. 2018 Jun 12. pii: 10.1038/s41388-018-0333.
    PubMed     Text format     Abstract available
    
    
    April 2018
12. PINAZZA M, Ghisi M, Minuzzo S, Agnusdei V, et al
    Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells.
    Oncogene. 2018 Apr 12. pii: 10.1038/s41388-018-0234.
    PubMed     Text format     Abstract available
    
    
    March 2018
13. ZHU Y, Lu L, Qiao C, Shan Y, et al
    Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor.
    Oncogene. 2018 Mar 7. pii: 10.1038/s41388-018-0157.
    PubMed     Text format     Abstract available
    
    
    February 2018
14. ABDUL-AZIZ AM, Shafat MS, Sun Y, Marlein CR, et al
    HIF1alpha drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia.
    Oncogene. 2018 Feb 28. pii: 10.1038/s41388-018-0151.
    PubMed     Text format     Abstract available
    
    
    
15. DI COSTANZO A, Del Gaudio N, Conte L, Dell'Aversana C, et al
    The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia.
    Oncogene. 2018 Feb 22. pii: 10.1038/s41388-018-0143.
    PubMed     Text format     Abstract available
    
    
    
16. WANG H, Bei L, Shah CA, Huang W, et al
    The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.
    Oncogene. 2018 Feb 20. pii: 10.1038/s41388-018-0131.
    PubMed     Text format     Abstract available
    
    
    January 2018
17. LARMONIE NSD, Arentsen-Peters TCJM, Obulkasim A, Valerio D, et al
    MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
    Oncogene. 2018;37:107-115.
    PubMed     Text format     Abstract available
    
    
    October 2017
18. HEYDT Q, Larrue C, Saland E, Bertoli S, et al
    Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
19. ABBACI A, Talbot H, Saada S, Gachard N, et al
    Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    September 2017
20. SERIO J, Ropa J, Chen W, Mysliwski M, et al
    The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
21. YOUN H, Lee HK, Sohn HR, Park UH, et al
    RaRF confers RA resistance by sequestering RAR to the nucleolus and regulating MCL1 in leukemia cells.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    August 2017
22. D'ABUNDO L, Callegari E, Bresin A, Chillemi A, et al
    Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    July 2017
23. WU TS, Tan CT, Chang CC, Lin BR, et al
    B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    June 2017
24. ZIMMERMANNOVA O, Doktorova E, Stuchly J, Kanderova V, et al
    An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
25. KANG SM, Rosales JL, Meier-Stephenson V, Kim S, et al
    Genome-wide loss-of-function genetic screening identifies opioid receptor mu1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
26. GUO A, Lu P, Lee J, Zhen C, et al
    HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment.
    Oncogene. 2017;36:3441-3449.
    PubMed     Text format     Abstract available
    
    
    
27. TSURUTA-KISHINO T, Koya J, Kataoka K, Narukawa K, et al
    Loss of p53 induces leukemic transformation in a murine model of Jak2 V617F-driven polycythemia vera.
    Oncogene. 2017;36:3300-3311.
    PubMed     Text format     Abstract available
    
    
    April 2017
28. BURGESS M, Mapp S, Mazzieri R, Cheung C, et al
    Increased FcgammaRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients.
    Oncogene. 2017;36:2366-2376.
    PubMed     Text format     Abstract available
    
    
    
29. MADAPURA HS, Nagy N, Ujvari D, Kallas T, et al
    Interferon gamma is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
30. SOCHALSKA M, Schuler F, Weiss JG, Prchal-Murphy M, et al
    MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis.
    Oncogene. 2017;36:2066-2073.
    PubMed     Text format     Abstract available
    
    
    March 2017
31. TSAI CT, So CW
    Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development.
    Oncogene. 2017;36:1753-1759.
    PubMed     Text format     Abstract available
    
    
    
32. TAKAHASHI H, Inoue J, Sakaguchi K, Takagi M, et al
    Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: